Երկիր: Ամերիկայի Միացյալ Նահանգներ
Լեզու: անգլերեն
Աղբյուրը: NLM (National Library of Medicine)
OMEPRAZOLE (UNII: KG60484QX9) (OMEPRAZOLE - UNII:KG60484QX9)
REMEDYREPACK INC.
ORAL
PRESCRIPTION DRUG
Omeprazole delayed-release capsules are indicated for short-term treatment of active duodenal ulcer in adults. Most patients heal within four weeks. Some patients may require an additional four weeks of therapy. Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence. Triple Therapy Omeprazole delayed-release capsules in combination with clarithromycin and amoxicillin, is indicated for treatment of patients with H. pylori infection and duodenal ulcer disease (active or up to 1-year history) to eradicate H. pylori in adults. Dual Therapy Omeprazole delayed-release capsules in combination with clarithromycin are indicated for treatment of patients with H. pylori infection and duodenal ulcer disease to eradicate H. pylori in adults. Among patients who fail therapy, omeprazole delayed-release capsules with clarithromycin is more likely to be associated with the development of clarithromycin resistance as compared with triple therapy. In patients who fail therapy, susceptibilit
Omeprazole delayed-release capsules USP, 10 mg, are size ‘3’ two piece hard gelatin capsule with light blue to blue body with “G” imprinting in black ink and orange cap with “G230” imprinting in black ink. The capsules are filled with white to off-white pellets. They are supplied as follows: NDC 68462-395-30 bottles of 30 NDC 68462-395-90 bottles of 90 NDC 68462-395-01 bottles of 100 NDC 68462-395-10 bottles of 1000 Omeprazole delayed-release capsules USP, 20 mg, are size ‘2’ two piece hard gelatin capsule with light blue to blue body with “G” imprinting in black ink and light blue to blue cap with “G231” imprinting in black ink. The capsules are filled with white to off-white pellets. They are supplied as follows: NDC 68462-396-30 bottles of 30 NDC 68462-396-90 bottles of 90 NDC 68462-396-01 bottles of 100 NDC 68462-396-10 bottles of 1000 Omeprazole delayed-release capsules USP, 40 mg, are size ‘1’ two piece hard gelatin capsule with orange body with ‘G’ imprinting in black ink and light blue to blue cap with ‘G232’ imprinting in black ink. The capsules are filled with white to off-white pellets. They are supplied as follows: NDC 68462-397-30 bottles of 30 NDC 68462-397-90 bottles of 90 NDC 68462-397-01 bottles of 100 NDC 68462-397-10 bottles of 1000 Storage Store omeprazole delayed-release capsules in a tight container protected from light and moisture. Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature].
Abbreviated New Drug Application
OMEPRAZOLE- OMEPRAZOLE CAPSULE, DELAYED RELEASE REMEDYREPACK INC. ---------- MEDICATION GUIDE Omeprazole Delayed-Release Capsules USP (oh mep' ra zole) Read this Medication Guide before you start taking omeprazole delayed-release capsules and each time you get a refill. There may be new information. This information does not take the place of talking with your doctor about your medical condition or your treatment. What is the most important information I should know about omeprazole delayed-release capsules? Omeprazole delayed-release capsules may help your acid-related symptoms, but you could still have serious stomach problems. Talk with your doctor. Omeprazole delayed-release capsules can cause serious side effects, including: • A type of kidney problem (acute interstitial nephritis). Some people who take proton pump inhibitor (PPI) medicines, including omeprazole delayed-release capsules, may develop a kidney problem called acute interstitial nephritis that can happen at any time during treatment with omeprazole delayed-release capsules. Call your doctor if you have a decrease in the amount that you urinate or if you have blood in your urine. • Diarrhea. Omeprazole delayed-release capsules may increase your risk of getting severe diarrhea. This diarrhea may be caused by an infection ( Clostridium difficile) in your intestines. Call your doctor right away if you have watery stool, stomach pain, and fever that does not go away. • Bone fractures. People who take multiple daily doses of PPI medicines for a long period of time (a year or longer) may have an increased risk of fractures of the hip, wrist, or spine. You should take omeprazole delayed-release capsules exactly as prescribed, at the lowest dose possible for your treatment and for the shortest time needed. Talk to your doctor about your risk of bone fracture if you take omeprazole delayed-release capsules. • Certain types of lupus erythematosus. Lupus erythematosus is an autoimmune disorder (the body’s immune cells attack other cells or organs Կարդացեք ամբողջական փաստաթուղթը
OMEPRAZOLE- OMEPRAZOLE CAPSULE, DELAYED RELEASE REMEDYREPACK INC. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE OMEPRAZOLE DELAYED-RELEASE CAPSULES SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR OMEPRAZOLE DELAYED-RELEASE CAPSULES. OMEPRAZOLE DELAYED-RELEASE CAPSULES, FOR ORAL USE INITIAL U.S. APPROVAL: 1989 RECENT MAJOR CHANGES 1. Warnings and Precautions, Fundic Gland Polyps ( 5.12) 02/2018 INDICATIONS AND USAGE Omeprazole delayed-release capsules are a proton pump inhibitor (PPI) indicated for the: Treatment of active duodenal ulcer in adults ( 1.1) Eradication _of Helicobacter pylori _to reduce the risk of duodenal ulcer recurrence in adults ( 1.2) Treatment of active benign gastric ulcer in adults ( 1.3) Treatment of symptomatic gastroesophageal reflux disease (GERD) in patients 2 years of age and older ( 1.4) Maintenance of healing of EE due to acid-mediated GERD in patients 2 years of age and older ( 1.6) Pathologic hypersecretory conditions in adults ( 1.7) DOSAGE AND ADMINISTRATION INDICATION RECOMMENDED ADULT ( 2.1) AND PEDIATRIC DOSAGE ( 2.2) Treatment of Active Duodenal Ulcer 20 mg once daily for 4 weeks; some patients may require an additional 4 weeks (2.1) _H. pylori_ Eradication to Reduce the Risk of Duodenal Ulcer Recurrence _Triple Therapy:_ Ome prazole 20 mg Each drug twice daily for 10 days (2.1) Amoxicillin 1000 mg Clarithromycin 500 mg _Dual Therapy:_ Ome prazole 40 mg once daily for 14 days Clarithromycin 500 mg three times daily for 14 days (2.1) Active Benign Gastric Ulcer 40 mg once daily for 4 to 8 weeks (2.1) Symptomatic GERD 20 mg once daily for up to 4 weeks (2.1) See full prescribing information for weight based dosing in pediatric patients 2 years of age and older (2.2) EE due to Acid-Mediated GERD 20 mg once daily for 4 to 8 weeks (2.1) See full prescribing information for weight based dosing in pediatric patients 2 years of age and older (2.2) Maintenance of Healing of EE due to Acid- Mediated GERD Կարդացեք ամբողջական փաստաթուղթը